Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma

Annals of Diagnostic Pathology

Volumn 19, Issue 5, 2015, Pages 330-334

  Chang, Hyeyoon ^a   Jung, Woon Yong ^b   Kang, Youngran ^c   Lee, Hyunjoo ^d   Kim, Aeree ^a   Kim, Baek Hui ^a  

^a Korea University College of Medicine   (South Korea)

^b Catholic Kwandong University   (South Korea)

^c Green Cross Corporation   (South Korea)

^d School of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Akt; CREB; ROR1; Stomach

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; KI 67 ANTIGEN; MEMBRANE PROTEIN; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 1; UNCLASSIFIED DRUG; CREB1 PROTEIN, HUMAN; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; ROR1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER TISSUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TISSUE MICROARRAY; TUMOR GROWTH; ADENOCARCINOMA; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; YOUNG ADULT;

EID: 84941599335     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2015.06.010     Document Type: Article

References (24)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. L. Teng, and J. Lu Cmet as a potential therapeutic target in gastric cancer (review) Int J Mol Med 32 2013 1247 1254
3. L. Zhang, J. Yang, J. Cai, and et al. A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy Sci Rep 3 2013 2992
4. P. Masiakowski, and R.D. Carroll A novel family of cell surface receptors with tyrosine kinase-like domain J Biol Chem 267 1992 26181 26190
5. S. Takeuchi, K. Takeda, I. Oishi, and et al. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation Genes Cells 5 2000 71 78
6. M. Nomi, I. Oishi, S. Kani, and et al. Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases Mol Cell Biol 21 2001 8329 8335
7. N. Borcherding, D. Kusner, G.H. Liu, and W. Zhang Ror1, an embryonic protein with an emerging role in cancer biology Prot Soc 5 2014 496 502
8. A.H. Daneshmanesh, A. Porwit, M. Hojjat-Farsangi, and et al. Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies Leuk Lymphoma 54 2013 843 850
9. S. Baskar, K.Y. Kwong, T. Hofer, and et al. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia Clin Cancer Res 14 2008 396 404
10. S. Zhang, L. Chen, B. Cui, and et al. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth PLoS One 7 2012 e31127
11. S. Zhang, L. Chen, J. Wang-Rodriguez, and et al. The onco-embryonic antigen ROR1 is expressed by a variety of human cancers Am J Pathol 181 2012 1903 1910
12. A. Gentile, L. Lazzari, S. Benvenuti, L. Trusolino, and P.M. Comoglio Ror1 is a pseudokinase that is crucial for met-driven tumorigenesis Cancer Res 71 2011 3132 3141
13. T. Fukuda, L. Chen, T. Endo, and et al. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a Proc Natl Acad Sci U S A 105 2008 3047 3052
14. F.T. Bosman, F. Carneiro, R.H. Hruban, and N.D. Theise WHO classification of tumours of the digestive system 2010 IARC Press Lyon
15. S.B. Edge, and American Joint Committee on Cancer AJCC cancer staging manual 7th ed. 2010 Springer New York; London [xiv, 648 p.]
16. W. Jung, K.D. Hong, W.Y. Jung, and et al. SIRT1 expression is associated with good prognosis in colorectal cancer Korean J Pathol 47 2013 332 339
17. H. Zhang, J. Qiu, C. Ye, and et al. ROR1 expression correlated with poor clinical outcome in human ovarian cancer Sci Rep 4 2014 5811
18. A.H. Daneshmanesh, E. Mikaelsson, M. Jeddi-Tehrani, and et al. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy Int J Cancer 123 2008 1190 1195
19. C. Fumarola, M.A. Bonelli, P.G. Petronini, and R.R. Alfieri Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer Biochem Pharmacol 90 2014 197 207
20. K. Du, and M. Montminy CREB is a regulatory target for the protein kinase Akt/PKB J Biol Chem 273 1998 32377 32379
21. K.M. Sakamoto, and D.A. Frank CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy Clin Cancer Res 15 2009 2583 2587
22. C. Perry, E.H. Sklan, and H. Soreq CREB regulates AChE-R-induced proliferation of human glioblastoma cells Neoplasia 6 2004 279 286
23. K.B. Lee, J. Park do, G. Choe, H.H. Kim, W.H. Kim, and H.S. Lee Protein expression status in mucosal and submucosal portions of early gastric cancers and their predictive value for lymph node metastasis APMIS 121 2013 926 937
24. J.P. MacKeigan, L.O. Murphy, and J. Blenis Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance Nat Cell Biol 7 2005 591 600